Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

Fig. 1

High expression of CHD4 is closely related to poor prognosis of patients with ovarian cancer. A The expression level of CHD4 in ovarian cancer tissue was higher than that in normal tissue (P < 0.001); B the relationship between the expression level of CHD4 and FIGO stage of serous ovarian cancer patients; C the relationship between the expression level of CHD4 and pathological grade of serous ovarian cancer; D Kaplan–Meier survival curve analysis showed that the overall survival of patients with high expression of CHD4 was inferior to that of those with low expression of CHD4 (p < 0.0001). ***p < 0.0001, **p < 0.01, *p < 0.05

Back to article page